Milton Boyer serves as Executive at ALBANY MOLECULAR RESEARCH INC, where they oversee executive responsibilities. Since joining the company, Milton Boyer has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 31, 2017 involved selling 42,109 shares valued at $915.9K.
Milton Boyer currently holds 42,109 shares of ALBANY MOLECULAR RESEARCH INC (AMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Milton Boyer has been a net neutral trader of AMRI stock. They have purchased $0 and sold $0 worth of shares.
Milton Boyer's most recent insider trade was on Aug 31, 2017, when they sold 42,109 shares at $21.75 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 5, 2017 | AMRI | $16.7K | Award | 1,043 | $16.04 | Discretionary |
| Jul 1, 2017 | AMRI | $35.2K | Payment | 1,619 | $21.72 | Discretionary |
| Mar 2, 2017 | AMRI | $4.0K | Payment | 277 | $14.52 | Discretionary |